Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
WHO issues warnings on fake copies of Novo Nordisk’s weight-loss drugs
The warnings were issued on fake drugs claiming to contain the active ingredient found in Novo Nordisk's diabetes drug Ozempic…
Emcure Pharma receives SEBI nod for IPO
The company gears up for market debut with SEBI approval for Rs 800 Crore IPO
US FDA puts Zentalis’ cancer drug studies on partial hold after patient deaths
The regulator's decision comes after two patients in the ovarian cancer study died due to presumed blood-related infection…
Venus Remedies clinches dual tender from UNICEF & PAHO
The company also secures a mandate from the world's oldest international public health agency for supplying essential cancer drugs…
Indian domestic formulations market expected to more than double, comfortably crossing INR 5.5…
The report attempts a deep dive into understanding the evolution of the DomForm sector and its emergence as a largely BGx market
Beacon Therapeutics’ AGTC-501 holds potential to become first gene therapy in XLRP space: GlobalData
AGTC-501 is highly anticipated as having the potential to become the first gene therapy specifically indicated for X-linked…
Rajnish Rohatgi appointed as CEO of Orchid AMS
He will be responsible for setting up a new division focused on promoting the rational use of anti-infectives and to favourably…
MSD Pharma to invest $38 million in Asia Pacific and Europe
Launched by MSD, IDEA Studios will be strategically located in asian and european innovation hubs to partner closely with…
AstraZeneca’s breast cancer drug combination fails in late-stage trial
The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients
Life sciences industry forecasts significant revenue from connected health within 5 years
Biopharma sees a sixfold surge in market-ready connected health products since 2021